Frakes James B reported AEMD

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001683168-26-007822

Machine-readable

Structured copy

Timestamps

Event (reported)

Oct 8, 2026

Published

Oct 13, 2026

Ingested by INSIDER

Nov 5, 02:12 UTC

Last re-read

Nov 5, 02:12 UTC

Extracted facts

Filer

Frakes James B

Role

Director, CFO/CEO

Transaction

Grant or awardAs filed: “A”

Asset

AETHLON MEDICAL INC

Ticker

AEMD

Shares

42.0K

Price per share

$0

Execution date (reported)

Oct 8, 2026

Owned after transaction

42.1K shares

Days from execution to publication

5

What this establishes

Frakes James B filed this Form 4 reporting a grant or award of AEMD on Oct 8, 2026. It became public on Oct 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director, CFO/CEO

Frakes James Bcik:0001185553

Issuer

AETHLON MEDICAL INCcik:0000882291

Revision history · 0

No field has changed since this record was first ingested.